Lung Cancer Clinical Trials in Oklahoma, OK

Explore lung cancer clinical trials in Oklahoma, OK, connecting patients to potential novel therapies.

Clinical Research in Oncology

Lung cancer clinical trials are driving progress in oncology by exploring potential treatment options. Therefore, our lung cancer clinical trials in Oklahoma, OK enable physicians to seamlessly integrate these clinical trials into their practices for better patient care.

Lung Cancer Resectable Stages II-IIIB

If you decide to participate, you’ll begin by reviewing and signing an Informed Consent Form that outlines the study in clear detail. Our research team will walk you through each step, answer your questions, and help you feel confident about your choice to join or withdraw whenever you wish.

Throughout the study, experienced physicians will closely monitor your health through regular exams and evaluations. Your participation may contribute to advancing future treatment options for people with resectable Stage II to IIIB lung cancer.

Enroll Now

Age

18 Years and older

Gender

All

Condition

Non-small cell lung cancer

Current Status

Recruiting

Location

Oklahoma City, OK

Study Information

Resectable Lung Cancer Clinical Trials

Study NameProtocol NumberSponsor
Non Small Cell Lung Cancer

MK2870- 019

Merck Sharp & Dohme LLC

Non-Small Cell Lung Cancer

Join advanced non-small cell lung cancer (NSCLC) clinical trials in Oklahoma City to explore potential novel treatments aimed at improving patient outcomes. These trials compare two drug combinations to determine which offers better results for individuals with specific gene mutations, potentially enhancing the immune system’s ability to fight cancer. With the guidance of expert physicians and all study-related procedures provided at no cost, participants receive exceptional care without the need for insurance. Moreover, your participation could help drive progress in lung cancer treatment.

Enroll Now

Age

18 Years and older

Gender

All

Condition

Non-Small Cell Lung Cancer

Current Status

Recruiting

Location

Oklahoma

Study Information

Non-Small Cell Lung Cancer

Study NameProtocol NumberSponsor
Non-Small Cell Lung Cancer

PAC 8 – D9075C00001

AstraZeneca

TRITON – D419ML00003

AstraZeneca